Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential.

Nanocarriers (synthetic/cell-based have attracted enormous interest for various therapeutic indications, including neurodegenerative disorders. A broader understanding of the impact of nanomedicines design is now required to enhance their translational potential. Nanoformulations in vivo journey is significantly affected by their physicochemical properties including the size, shape, hydrophobicity, elasticity, and surface charge/chemistry/morphology, which play a role as an interface with the biological environment. Understanding protein corona formation is crucial in characterizing nanocarriers and evaluating their interactions with biological systems. In this review, the types and properties of the brain-targeted nanocarriers are discussed. The biological factors and nanocarriers properties affecting their in vivo behavior are elaborated. The compositional description of cell culture and biological matrices, including proteins potentially relevant to protein corona built-up on nanoformulation especially for brain administration, is provided. Analytical techniques of characterizing nanocarriers in complex matrices, their advantages, limitations, and implementation challenges in industrial GMP environment are discussed. The uses of orthogonal complementary characterization approaches of nanocarriers are also covered.

[1]  S. Mitragotri,et al.  Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[2]  V. Jain,et al.  Nanomedicines based drug delivery systems for anti-cancer targeting and treatment. , 2015, Current drug delivery.

[3]  T. Iwamoto Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. , 2013, Biological & pharmaceutical bulletin.

[4]  C. Fan,et al.  Protein corona-mediated mitigation of cytotoxicity of graphene oxide. , 2011, ACS nano.

[5]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[6]  J. Feijen,et al.  Highly efficacious and specific anti‐glioma chemotherapy by tandem nanomicelles co‐functionalized with brain tumor‐targeting and cell‐penetrating peptides , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Alexander V Kabanov,et al.  Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. , 2017, Biomaterials.

[8]  Markus Schulz,et al.  Fetal Bovine Serum (FBS): Past - Present - Future. , 2018, ALTEX.

[9]  Albert Duschl,et al.  Time evolution of the nanoparticle protein corona. , 2010, ACS nano.

[10]  Thomas J Webster,et al.  Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity , 2014, International journal of nanomedicine.

[11]  A. Fonteh,et al.  Protein Analysis in Human Cerebrospinal Fluid: Physiological Aspects, Current Progress and Future Challenges , 2005, Disease markers.

[12]  Caterina Minelli,et al.  A comparison of techniques for size measurement of nanoparticles in cell culture medium , 2016 .

[13]  P. Davy,et al.  Monocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue – Evaluations on Monocyte-Based Delivery System for the Central Nervous System , 2016, PloS one.

[14]  J. Kreuter,et al.  Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? , 2014, Advanced drug delivery reviews.

[15]  C. Solans,et al.  Characterization of Polymeric Nanoparticle Dispersions for Biomedical Applications: Size, Surface Charge and Stability. , 2018, Pharmaceutical nanotechnology.

[16]  Elisabetta Muntoni,et al.  Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery , 2018, Expert opinion on drug delivery.

[17]  T. Yonezawa,et al.  Synovial fluid total protein concentration as a possible marker for canine idiopathic polyarthritis , 2015, The Journal of veterinary medical science.

[18]  G. Sancini,et al.  Artificial apolipoprotein corona enables nanoparticle brain targeting. , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[19]  Jing Zhao,et al.  Revealing the immune perturbation of black phosphorus nanomaterials to macrophages by understanding the protein corona , 2018, Nature Communications.

[20]  F. Schacher,et al.  Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction. , 2016, The international journal of biochemistry & cell biology.

[21]  A. Mitra,et al.  Next generation drug delivery: circulatory cells-mediated nanotherapeutic approaches , 2017, Expert opinion on drug delivery.

[22]  Paul R. Lockman,et al.  Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability , 2004, Journal of drug targeting.

[23]  Ronald J Moore,et al.  Characterization of the human blood plasma proteome , 2005, Proteomics.

[24]  Mayur M. Patel,et al.  Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain , 2017, CNS Drugs.

[25]  Gerhard Gstraunthaler,et al.  Zell- und Gewebekultur , 2013 .

[26]  Sun Young Min,et al.  Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Qing Yao,et al.  Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types , 2018, Front. Pharmacol..

[28]  Zhiyuan Hu,et al.  Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns. , 2017, Colloids and surfaces. B, Biointerfaces.

[29]  T. Snoeks,et al.  Effect of PLGA NP size on efficiency to target traumatic brain injury. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Sarika Wairkar,et al.  Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity. , 2018, International journal of biological macromolecules.

[31]  P. Altevogt,et al.  Body fluid derived exosomes as a novel template for clinical diagnostics , 2011, Journal of Translational Medicine.

[32]  E. MetwalliNabila WHO RECOMMENDATIONS FOR THE PRODUCTION, CONTROL AND REGULATION OF HUMAN PLASMA FOR FRACTIONATION , 2011 .

[33]  Samir Mitragotri,et al.  Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude , 2018, Nature Communications.

[34]  Nathan McDannold,et al.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. , 2014, Advanced drug delivery reviews.

[35]  E. Diamandis,et al.  Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery , 2017, Critical reviews in clinical laboratory sciences.

[36]  Erno Pungor,et al.  Proteomic Analysis for the Assessment of Different Lots of Fetal Bovine Serum as a Raw Material for Cell Culture. Part IV. Application of Proteomics to the Manufacture of Biological Drugs , 2008, Biotechnology progress.

[37]  Tushar Patel,et al.  Circulating Extracellular Vesicles in Human Disease. , 2018, The New England journal of medicine.

[38]  P. Zahedi,et al.  Recent advances in drug delivery strategies for treatment of ovarian cancer , 2012, Expert opinion on drug delivery.

[39]  Raimo Hartmann,et al.  Stiffness-dependent in vitro uptake and lysosomal acidification of colloidal particles. , 2015, Angewandte Chemie.

[40]  N. Abbott Blood–brain barrier structure and function and the challenges for CNS drug delivery , 2013, Journal of Inherited Metabolic Disease.

[41]  S. Mitragotri,et al.  Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. , 2015, ACS nano.

[42]  A. Doucet-Panaye,et al.  Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches , 2016, SAR and QSAR in environmental research.

[43]  Pablo Játiva,et al.  Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases. , 2018, Nanomedicine.

[44]  D. Weitz,et al.  Interaction of spin-labeled HPMA-based nanoparticles with human blood plasma proteins - the introduction of protein-corona-free polymer nanomedicine. , 2018, Nanoscale.

[45]  Kevin Braeckmans,et al.  Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. , 2013, ACS nano.

[46]  Peter Kearns,et al.  Physico-chemical properties of manufactured nanomaterials - Characterisation and relevant methods. An outlook based on the OECD Testing Programme , 2018, Regulatory toxicology and pharmacology : RTP.

[47]  P. Botella,et al.  Protein Adsorption From Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity. , 2015, ACS applied materials & interfaces.

[48]  B. Zlokovic The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[49]  N. Baldini,et al.  Exosomes: novel effectors of human platelet lysate activity. , 2014, European cells & materials.

[50]  Jing Qin,et al.  Exploiting macrophages as targeted carrier to guide nanoparticles into glioma , 2016, Oncotarget.

[51]  Vivek Agrahari,et al.  Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities. , 2018, Drug discovery today.

[52]  S. Benita,et al.  Non-systemic delivery of topical brimonidine to the brain: A neuro-ocular tissue distribution study , 2006, Journal of drug targeting.

[53]  María José Marchant,et al.  Metal Nanoparticles for the Treatment and Diagnosis of Neurodegenerative Brain Diseases. , 2017, Current pharmaceutical design.

[54]  T. Ishida,et al.  Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[55]  Ping-Chang Lin,et al.  Techniques for physicochemical characterization of nanomaterials. , 2014, Biotechnology advances.

[56]  A. Jones,et al.  Nanoparticle geometry and surface orientation influence mode of cellular uptake. , 2013, ACS nano.

[57]  W. Robberecht,et al.  Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery , 2014, Expert opinion on investigational drugs.

[58]  U. Schlötzer-Schrehardt,et al.  Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[59]  A. Silva,et al.  Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization , 2018, Journal of Nanobiotechnology.

[60]  J. Tsibouklis,et al.  Nano carriers for drug transport across the blood–brain barrier , 2017, Journal of drug targeting.

[61]  M. Mahmoudi,et al.  Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. , 2016, Biomaterials.

[62]  D. Van Roost,et al.  The influence of cerebrospinal fluid on blood coagulation and the implications for ventriculovenous shunting. , 2019, Journal of neurosurgery.

[63]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[64]  Jinchao Zhang,et al.  Traceable Nanoparticle Delivery of Small Interfering RNA and Retinoic Acid with Temporally Release Ability to Control Neural Stem Cell Differentiation for Alzheimer's Disease Therapy , 2016, Advanced materials.

[65]  S. Krol,et al.  Protein corona: implications for nanoparticle interactions with pulmonary cells , 2017, Particle and Fibre Toxicology.

[66]  S. Tamilvanan,et al.  In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of ibuprofen , 2006, AAPS PharmSciTech.

[67]  Raquel Ferreira,et al.  Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[68]  X. Cui,et al.  ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood–brain barrier , 2018, Journal of Nanobiotechnology.

[69]  Nobuhiro Nishiyama,et al.  Nanomedicine: nanocarriers shape up for long life. , 2007, Nature nanotechnology.

[70]  Jennifer I. Hare,et al.  Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.

[71]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.

[72]  Cheng Dong,et al.  Design strategies and applications of circulating cell-mediated drug delivery systems. , 2015, ACS biomaterials science & engineering.

[73]  Roger M. Leblanc,et al.  Crossing the blood‐brain barrier with nanoparticles , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[74]  Quanyin Hu,et al.  Dual targeted nanocarrier for brain ischemic stroke treatment. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[75]  V. Ceña,et al.  Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis. , 2016, Nanomedicine.

[76]  Peter J Millett,et al.  High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis , 2007, Arthritis research & therapy.

[77]  D. Devos,et al.  Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment , 2015, Transfusion.

[78]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[79]  Farooq Ali Khan,et al.  Nanoemulsion: Concepts, development and applications in drug delivery , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Nguyen T. K. Thanh,et al.  Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. , 2018, Nanoscale.

[81]  R. Schiffelers,et al.  Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.

[82]  C R Merril,et al.  Two-dimensional gel electrophoresis of cerebrospinal fluid proteins. , 1980, Clinical chemistry.

[83]  Yong Song Gho,et al.  Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum , 2014, Journal of extracellular vesicles.

[84]  C. Teunissen,et al.  Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. , 2014, Journal of proteomics.

[85]  W. Pardridge Molecular Trojan horses for blood-brain barrier drug delivery. , 2006, Discovery medicine.

[86]  Ching-Li Tseng,et al.  Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products , 2018, Front. Med..

[87]  Kaoxiang Sun,et al.  Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease , 2018, International journal of nanomedicine.

[88]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[89]  Elizabeth Nance,et al.  A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue , 2012, Science Translational Medicine.

[90]  Venkatareddy Nadithe,et al.  Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.

[91]  Warren C W Chan,et al.  Effect of gold nanoparticle aggregation on cell uptake and toxicity. , 2011, ACS nano.

[92]  J. Kaplan,et al.  Platelet removal from the circulation by the liver and spleen. , 1978, The American journal of physiology.

[93]  J. Dernouchamps The proteins of the aqueous humour , 1982, Documenta Ophthalmologica.

[94]  Ying Fan,et al.  Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases. , 2018, Critical reviews in therapeutic drug carrier systems.

[95]  Otto L Muskens,et al.  Interactions of human endothelial cells with gold nanoparticles of different morphologies. , 2012, Small.

[96]  S. Hamann,et al.  Osmolality of Cerebrospinal Fluid from Patients with Idiopathic Intracranial Hypertension (IIH) , 2016, PloS one.

[97]  H. Sheardown,et al.  Growth factors in the tear film: role in tissue maintenance, wound healing, and ocular pathology. , 2007, The ocular surface.

[98]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[99]  Thierry Burnouf,et al.  Extracellular Microvesicles as New Industrial Therapeutic Frontiers. , 2019, Trends in biotechnology.

[100]  Nitish Thakor,et al.  Biocompatible Red Fluorescent Organic Nanoparticles with Tunable Size and Aggregation‐Induced Emission for Evaluation of Blood–Brain Barrier Damage , 2016, Advanced materials.

[101]  Philip Demokritou,et al.  High Resolution Characterization of Engineered Nanomaterial Dispersions in Complex Media Using Tunable Resistive Pulse Sensing Technology , 2014, ACS nano.

[102]  Zhi Zhu,et al.  In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier. , 2014, ACS applied materials & interfaces.

[103]  Diego Stéfani T. Martinez,et al.  Silver nanoparticle protein corona and toxicity: a mini-review , 2015, Journal of Nanobiotechnology.

[104]  S. Rome,et al.  Depleting extracellular vesicles from fetal bovine serum alters proliferation and differentiation of skeletal muscle cells in vitro , 2016, BMC Biotechnology.

[105]  Ravish J. Patel,et al.  Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies. , 2016, Current Drug Delivery.

[106]  M. Wiesner,et al.  Characterization of surface hydrophobicity of engineered nanoparticles. , 2012, Journal of hazardous materials.

[107]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[108]  Iseult Lynch,et al.  Serum heat inactivation affects protein corona composition and nanoparticle uptake. , 2010, Biomaterials.

[109]  Huile Gao,et al.  Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona. , 2018, ACS applied materials & interfaces.

[110]  R. Haag,et al.  Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties. , 2017, Biomacromolecules.

[111]  C. Svendsen,et al.  GDNF delivery using human neural progenitor cells in a rat model of ALS. , 2005, Human gene therapy.

[112]  Jau-Song Yu,et al.  Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandem mass spectrometry. , 2011, Analytical biochemistry.

[113]  A. Gürel,et al.  Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome , 2008, Eye.

[114]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[115]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[116]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[117]  S. Kim,et al.  Glycosaminoglycans from bovine eye vitreous humour and interaction with collagen type II , 2018, Glycoconjugate Journal.

[118]  D. Strunk,et al.  International Forum on GMP‐grade human platelet lysate for cell propagation , 2018, Vox sanguinis.

[119]  K. Tsubota,et al.  Serum Application for the Treatment of Ocular Surface Disorders , 2000, International ophthalmology clinics.

[120]  V. Mishra,et al.  Dendrimer-mediated approaches for the treatment of brain tumor , 2016, Journal of biomaterials science. Polymer edition.

[121]  G. Ugolini,et al.  Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. , 2009, Journal of Alzheimer's disease : JAD.

[122]  Vivek Agrahari,et al.  Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology , 2016, Journal of Neuroimmune Pharmacology.

[123]  S. Madi,et al.  Superparamagnetic nanoparticle‐enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization , 2017, Journal of magnetic resonance imaging : JMRI.

[124]  Manfred Westphal,et al.  Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration. , 2017, Pediatric neurology.

[125]  Caterina Minelli,et al.  Size and ζ-Potential Measurement of Silica Nanoparticles in Serum Using Tunable Resistive Pulse Sensing. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[126]  Jungwon Yoon,et al.  Osmotin-loaded magnetic nanoparticles with electromagnetic guidance for the treatment of Alzheimer's disease. , 2017, Nanoscale.

[127]  W. Baumgartner,et al.  Generation‐6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[128]  Yun Hou,et al.  Gene Therapy of Multiple Sclerosis Using Interferon β-Secreting Human Bone Marrow Mesenchymal Stem Cells , 2013, BioMed research international.

[129]  A. Milani,et al.  Crucial role of the protein corona for the specific targeting of nanoparticles. , 2015, Nanomedicine.

[130]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[131]  Kenneth A. Dawson,et al.  Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. , 2012, ACS nano.

[132]  V. Vlassov,et al.  [Characteristics of exosomes andmicroparticles discovered in human tears]. , 2016, Biomeditsinskaia khimiia.

[133]  Kinam Park,et al.  Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. , 2013, International journal of pharmaceutics.

[134]  Wolfgang J. Parak,et al.  Protein corona formation around nanoparticles – from the past to the future , 2014 .

[135]  Mengsu Yang,et al.  Efficient RNA drug delivery using red blood cell extracellular vesicles , 2018, Nature Communications.

[136]  Shantikumar V. Nair,et al.  Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma , 2017, Scientific Reports.

[137]  Nir Lipsman,et al.  Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound , 2018, Nature Communications.

[138]  B. Damato,et al.  Proteomic Analyses of the Vitreous Humour , 2012, Mediators of inflammation.

[139]  D. Strunk,et al.  International Forum on GMP‐grade human platelet lysate for cell propagation: summary , 2018, Vox sanguinis.

[140]  Roberto Cingolani,et al.  Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.

[141]  Pascal Richette,et al.  Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents , 2012, Expert opinion on drug delivery.

[142]  Peijun Wang,et al.  A Novel Magnetic Nanoparticle for Early Detection of Amyloid Plaques in Alzheimer's Disease. , 2018, Archives of medical research.

[143]  T. Hadjistilianou,et al.  Analysis of aqueous humour proteins in patients with retinoblastoma , 2012, Clinical & experimental ophthalmology.

[144]  Richa Gupta,et al.  Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[145]  Mojca Pavlin,et al.  Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona , 2017, PloS one.

[146]  Sankar Basu,et al.  Inner-View of Nanomaterial Incited Protein Conformational Changes: Insights into Designable Interaction , 2018, Research.

[147]  Warren C W Chan,et al.  Nanoparticle-blood interactions: the implications on solid tumour targeting. , 2015, Chemical communications.

[148]  Y. Tabata,et al.  Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[149]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[150]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[151]  Mark E. Davis,et al.  Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core , 2015, Proceedings of the National Academy of Sciences.

[152]  Liang Jiang,et al.  Study on the interaction of graphene oxide‑silver nanocomposites with bovine serum albumin and the formation of nanoparticle-protein corona. , 2018, International journal of biological macromolecules.

[153]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[154]  A. Cianciulli,et al.  Microglia‐derived extracellular vesicles in Alzheimer's Disease: A double‐edged sword , 2018, Biochemical pharmacology.

[155]  Peter Ramge,et al.  Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.

[156]  Candace C. Fleischer,et al.  Nanoparticle–Cell Interactions: Molecular Structure of the Protein Corona and Cellular Outcomes , 2014, Accounts of chemical research.

[157]  M. Nasr Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery , 2016, Drug delivery.

[158]  M. M. Lunzer,et al.  Comparative in Vivo Investigation of Intrathecal and Intracerebroventricular Administration with Melanocortin Ligands MTII and AGRP into Mice. , 2017, ACS chemical neuroscience.

[159]  Jessica M. Rosenholm,et al.  Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier , 2016, PloS one.

[160]  Huw D. Summers,et al.  Quantitative characterization of nanoparticle agglomeration within biological media , 2012, Journal of Nanoparticle Research.

[161]  Mark E. Davis,et al.  Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor , 2013, Proceedings of the National Academy of Sciences.

[162]  R. Müller,et al.  Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.

[163]  Nicolas Bertrand,et al.  Anti‐polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[164]  P. Schurtenberger,et al.  Characterizing nanoparticles in complex biological media and physiological fluids with depolarized dynamic light scattering. , 2015, Nanoscale.

[165]  Yaping Li,et al.  Treatment of Malignant Brain Tumor by Tumor‐Triggered Programmed Wormlike Micelles with Precise Targeting and Deep Penetration , 2016 .

[166]  Kenneth W. Witwer,et al.  Extracellular vesicle–depleted fetal bovine and human sera have reduced capacity to support cell growth , 2015, Journal of extracellular vesicles.

[167]  Kenneth J. Shea,et al.  Tuning the Protein Corona of Hydrogel Nanoparticles: The Synthesis of Abiotic Protein and Peptide Affinity Reagents. , 2016, Accounts of chemical research.

[168]  H. Luhmann,et al.  Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates , 2018, Advanced science.

[169]  K. Landfester,et al.  Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. , 2016, Nanoscale.

[170]  Huile Gao,et al.  Progress and perspectives on targeting nanoparticles for brain drug delivery , 2016, Acta pharmaceutica Sinica. B.

[171]  D. Dexter,et al.  L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[172]  M. Moses,et al.  Nanoparticle elasticity directs tumor uptake , 2018, Nature Communications.

[173]  G. Wang,et al.  Quercetin-loaded freeze-dried nanomicelles: Improving absorption and anti-glioma efficiency in vitro and in vivo. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[174]  Pia Siljander,et al.  Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum , 2018, Journal of extracellular vesicles.

[175]  S. Baboota,et al.  Ligand conjugation: An emerging platform for enhanced brain drug delivery , 2018, Brain Research Bulletin.

[176]  Ashutosh Chilkoti,et al.  Co‐opting biology to deliver drugs , 2014, Biotechnology and bioengineering.

[177]  James P K Armstrong,et al.  Strategic design of extracellular vesicle drug delivery systems. , 2018, Advanced drug delivery reviews.

[178]  Lu Wen,et al.  Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in vitro and in vivo evaluation. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[179]  The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. , 2011, Biomaterials.

[180]  Jian-Qing Gao,et al.  Exosomes as novel bio-carriers for gene and drug delivery. , 2017, International journal of pharmaceutics.

[181]  B. Zhang,et al.  LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. , 2013, Biomaterials.

[182]  Samir Mitragotri,et al.  Non-affinity factors modulating vascular targeting of nano- and microcarriers. , 2016, Advanced drug delivery reviews.

[183]  Peng Zhang,et al.  Insight into the preformed albumin corona on in vitro and in vivo performances of albumin-selective nanoparticles , 2018, Asian journal of pharmaceutical sciences.

[184]  Ronnie H. Fang,et al.  A facile approach to functionalizing cell membrane‐coated nanoparticles with neurotoxin‐derived peptide for brain‐targeted drug delivery , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[185]  F. Ahmad,et al.  CNS drug delivery systems: novel approaches. , 2009, Recent patents on drug delivery & formulation.

[186]  Pieter Vader,et al.  Extracellular vesicles as drug delivery systems: lessons from the liposome field. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[187]  Luis M Liz-Marzán,et al.  In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape. , 2018, Nanoscale.

[188]  Yi-xiao Luo,et al.  Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[189]  Yang Yang,et al.  Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma , 2017, Drug delivery.

[190]  Michael A. Briggs,et al.  Nanofiber-based delivery of therapeutic peptides to the brain. , 2013, ACS nano.

[191]  P. Tran,et al.  Modulation of serum albumin protein corona for exploring cellular behaviors of fattigation-platform nanoparticles. , 2018, Colloids and surfaces. B, Biointerfaces.

[192]  Ling Zhang,et al.  Dopamine‐loaded blood exosomes targeted to brain for better treatment of Parkinson's disease , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[193]  Kaj Blennow,et al.  Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients , 2002, Neuroreport.

[194]  Nunzio Iraci,et al.  Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles , 2016, International journal of molecular sciences.

[195]  J. Sousa,et al.  Modeling of ultra‐small lipid nanoparticle surface charge for targeting glioblastoma , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[196]  Lihong Liu,et al.  Modern methods for delivery of drugs across the blood-brain barrier. , 2012, Advanced drug delivery reviews.

[197]  Mary E Napier,et al.  The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[198]  Shu Zhang,et al.  Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. , 2013, Biomaterials.

[199]  Patrícia M. Carvalho,et al.  Application of Light Scattering Techniques to Nanoparticle Characterization and Development , 2018, Front. Chem..

[200]  A. Banerjee,et al.  Dual functionalized liposome‐mediated gene delivery across triple co‐culture blood brain barrier model and specific in vivo neuronal transfection , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[201]  S. Botchway,et al.  Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics , 2018, ChemNanoMat : chemistry of nanomaterials for energy, biology and more.

[202]  Tianzhi Yang,et al.  Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio , 2014, Pharmaceutical Research.

[203]  Svetlana Gelperina,et al.  Transport of drugs across the blood-brain barrier by nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[204]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[205]  W. Grizzle,et al.  Exosomes are endogenous nanoparticles that can deliver biological information between cells. , 2013, Advanced drug delivery reviews.

[206]  Chi Zhang,et al.  A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer's Disease Treatment. , 2018, Current pharmaceutical biotechnology.

[207]  Y. Yeo,et al.  Controlled Drug Release from Pharmaceutical Nanocarriers. , 2015, Chemical engineering science.

[208]  J. Lellouche,et al.  The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model , 2015, Journal of Nanobiotechnology.

[209]  Seyed Moein Moghimi,et al.  Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. , 2017, Nature nanotechnology.

[210]  F. Rossi,et al.  Characterisation of nanomaterial hydrophobicity using engineered surfaces , 2017, Journal of Nanoparticle Research.

[211]  O. Eniola-Adefeso,et al.  Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow. , 2017, Acta biomaterialia.

[212]  J. Guan,et al.  Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption , 2018, Nature Communications.

[213]  S. Álvarez,et al.  In vivo delivery of siRNA to the brain by carbosilane dendrimer. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[214]  F. Danhier,et al.  To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[215]  Christine Dufès,et al.  Applications of dendrimers for brain delivery and cancer therapy. , 2014, Nanomedicine.

[216]  V. Puntes,et al.  Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona. , 2017, Bioconjugate chemistry.

[217]  D. Devos,et al.  Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. , 2014, Blood reviews.

[218]  Limin Mu,et al.  Development of functional docetaxel nanomicelles for treatment of brain glioma , 2018, Artificial cells, nanomedicine, and biotechnology.

[219]  Wenbo Zhan,et al.  Convection enhanced delivery of chemotherapeutic drugs into brain tumour , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[220]  S. Retterer,et al.  Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. , 2013, Nanoscale.

[221]  B. Pickard,et al.  Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[222]  Sandor Balog,et al.  Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. , 2015, Chemical Society reviews.

[223]  E. Tasciotti,et al.  Bioinspired approaches for cancer nanotheranostics. , 2017, Nanomedicine.

[224]  Wei Lu,et al.  Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[225]  R. Flaumenhaft,et al.  Platelet alpha-granules: basic biology and clinical correlates. , 2009, Blood reviews.

[226]  Chor Yong Tay,et al.  Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.

[227]  Francesco Salvatore,et al.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. , 2016, Nanomedicine.

[228]  Parag Aggarwal,et al.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.

[229]  Katharina Gaus,et al.  Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release. , 2017, Nature nanotechnology.

[230]  K. Blennow,et al.  Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[231]  Raimo Hartmann,et al.  Temperature: the "ignored" factor at the NanoBio interface. , 2013, ACS nano.

[232]  A. Saleh,et al.  Applications of nanoparticle systems in drug delivery technology , 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[233]  E. Nance,et al.  Colloidal stability as a determinant of nanoparticle behavior in the brain. , 2018, Colloids and surfaces. B, Biointerfaces.

[234]  M. Mahmoudi,et al.  Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.

[235]  T. Burnouf,et al.  Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion , 2014, New Biotechnology.

[236]  F. Rossi,et al.  Direct quantification of nanoparticle surface hydrophobicity , 2018, Communications Chemistry.

[237]  F. Caruso,et al.  Role of the Protein Corona Derived from Human Plasma in Cellular Interactions between Nanoporous Human Serum Albumin Particles and Endothelial Cells. , 2017, Bioconjugate chemistry.

[238]  Wolfgang J Parak,et al.  A Decade of the Protein Corona. , 2017, ACS nano.

[239]  Hong-ming Ding,et al.  Computer simulation of the role of protein corona in cellular delivery of nanoparticles. , 2014, Biomaterials.

[240]  M. Basri,et al.  Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics , 2018, International journal of nanomedicine.

[241]  Beom-Jin Lee,et al.  Protein corona: a new approach for nanomedicine design , 2017, International journal of nanomedicine.

[242]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[243]  Eran A Barnoy,et al.  The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study. , 2017, Nanomedicine.

[244]  Charlotte Lawson,et al.  Microvesicles and exosomes: new players in metabolic and cardiovascular disease. , 2016, The Journal of endocrinology.

[245]  S. Rapoport Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications , 2000, Cellular and Molecular Neurobiology.

[246]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[247]  Baoquan Ding,et al.  Tunable Rigidity of (Polymeric Core)–(Lipid Shell) Nanoparticles for Regulated Cellular Uptake , 2015, Advanced materials.

[248]  Han‐Gon Choi,et al.  Rabies Virus‐Inspired Silica‐Coated Gold Nanorods as a Photothermal Therapeutic Platform for Treating Brain Tumors , 2017, Advanced materials.

[249]  D. Sen,et al.  Immunoglobulins in human aqueous humour. , 1977, The British journal of ophthalmology.

[250]  G. Caracciolo,et al.  Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells. , 2017, Colloids and surfaces. B, Biointerfaces.

[251]  K. Landfester,et al.  Beyond the protein corona - lipids matter for biological response of nanocarriers. , 2018, Acta biomaterialia.

[252]  Katharina Landfester,et al.  The Transferability from Animal Models to Humans: Challenges Regarding Aggregation and Protein Corona Formation of Nanoparticles. , 2018, Biomacromolecules.

[253]  Ji Hee Kang,et al.  Investigation on the effect of nanoparticle size on the blood–brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice , 2018, Journal of drug targeting.

[254]  Dirk Strunk,et al.  Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? , 2016, Biomaterials.

[255]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[256]  Tae Geol Lee,et al.  Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[257]  Yang Yu,et al.  A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration. , 2018, Journal of biomedical nanotechnology.

[258]  S. Mornet,et al.  Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration , 2014, Journal of thrombosis and haemostasis : JTH.

[259]  Morteza Mahmoudi,et al.  Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.

[260]  Jennifer E Gagner,et al.  Effect of gold nanoparticle morphology on adsorbed protein structure and function. , 2011, Biomaterials.

[261]  S. Alonso,et al.  PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization , 2018, International journal of pharmaceutics.

[262]  P. Djupesland,et al.  The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview. , 2014, Therapeutic delivery.

[263]  C. Taghibiglou,et al.  Novel Central Nervous System Drug Delivery Systems , 2014, Chemical biology & drug design.

[264]  Baoan Chen,et al.  Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy , 2017, International journal of nanomedicine.

[265]  Chih-Kuang Yeh,et al.  Combining Microbubbles and Ultrasound for Drug Delivery to Brain Tumors: Current Progress and Overview , 2014, Theranostics.

[266]  Fulvio Magni,et al.  Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier. , 2018, ACS nano.

[267]  Iseult Lynch,et al.  Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.

[268]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[269]  Frank A. Witzmann,et al.  Silver Nanoparticle Protein Corona Composition in Cell Culture Media , 2013, PloS one.

[270]  Samir Mitragotri,et al.  Impact of particle elasticity on particle‐based drug delivery systems☆ , 2017, Advanced drug delivery reviews.

[271]  Xue-Qing Zhang,et al.  Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials. , 2018, Small.

[272]  J. Rossignol,et al.  PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice , 2017, International journal of molecular sciences.

[273]  A. Sinclair,et al.  Cerebrospinal fluid and lumbar puncture: a practical review , 2012, Journal of Neurology.

[274]  Thierry Burnouf,et al.  Expansion of adipose tissue mesenchymal stromal progenitors in serum‐free medium supplemented with virally inactivated allogeneic human platelet lysate , 2011, Transfusion.

[275]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[276]  L. Pereira de Almeida,et al.  Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[277]  Koen Raemdonck,et al.  Therapeutic and diagnostic applications of extracellular vesicles. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[278]  A. Neves,et al.  Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E , 2016, Journal of Nanobiotechnology.

[279]  D. Aarsland,et al.  Isoelectric point region pI≈7.4 as a treasure island of abnormal proteoforms in blood , 2016, Discoveries.

[280]  S. Savić,et al.  Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances. , 2017, International journal of pharmaceutics.

[281]  A. De Vizcaya-Ruiz,et al.  A comparison of the human and mouse protein corona profiles of functionalized SiO2 nanocarriers. , 2017, Nanoscale.

[282]  Gert Storm,et al.  Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release , 2010, Pharmaceutical Research.

[283]  Guixue Wang,et al.  Penetration of blood–brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system , 2017, International journal of nanomedicine.

[284]  B. Honoré,et al.  Proteomic analysis of aqueous humour from patients with acute corneal rejection. , 2005, Acta ophthalmologica Scandinavica.

[285]  M. Rubner,et al.  Macrophages with cellular backpacks for targeted drug delivery to the brain. , 2017, Biomaterials.

[286]  W. Parak,et al.  Techniques for the experimental investigation of the protein corona. , 2017, Current opinion in biotechnology.

[287]  M. Papi,et al.  Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells. , 2017, Nanoscale.

[288]  Ajazuddin,et al.  Recent advancements in liposomes targeting strategies to cross blood‐brain barrier (BBB) for the treatment of Alzheimer's disease , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[289]  R. Tripathi,et al.  Protein composition of human aqueous humor: SDS-PAGE analysis of surgical and post-mortem samples. , 1989, Experimental eye research.

[290]  Sara Linse,et al.  Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid , 2010, PloS one.

[291]  K. Houkin,et al.  Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome , 2010, Brain Research.

[292]  Samir Mitragotri,et al.  Red blood cell-mimicking synthetic biomaterial particles , 2009, Proceedings of the National Academy of Sciences.

[293]  Xiaowei Dong,et al.  Current Strategies for Brain Drug Delivery , 2018, Theranostics.

[294]  A. Khan,et al.  Recent progress of drug nanoformulations targeting to brain , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[295]  Samir Mitragotri,et al.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium , 2013, Proceedings of the National Academy of Sciences.

[296]  F Ornaghi,et al.  ApoE‐modified solid lipid nanoparticles: A feasible strategy to cross the blood‐brain barrier , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[297]  W. Lam,et al.  Protein Corona in Response to Flow: Effect on Protein Concentration and Structure. , 2018, Biophysical journal.

[298]  E. Mastrobattista,et al.  Drug delivery with living cells. , 2016, Advanced drug delivery reviews.

[299]  Jie Zheng,et al.  Clearance Pathways and Tumor Targeting of Imaging Nanoparticles. , 2015, ACS nano.

[300]  K. Makino,et al.  Biodistribution of colloidal gold nanoparticles after intravenous injection: Effects of PEGylation at the same particle size. , 2018, Bio-medical materials and engineering.

[301]  W. Frey,et al.  Intranasal delivery of cells to the brain. , 2009, European journal of cell biology.

[302]  P. Rameshwar,et al.  Stem cell delivery of therapies for brain disorders , 2014, Clinical and Translational Medicine.

[303]  Yoshinobu Manome,et al.  Cell-Based in Vitro Blood–Brain Barrier Model Can Rapidly Evaluate Nanoparticles’ Brain Permeability in Association with Particle Size and Surface Modification , 2014, International journal of molecular sciences.

[304]  P. Kingshott,et al.  The influence of nanostructured materials on biointerfacial interactions. , 2012, Advanced drug delivery reviews.

[305]  H. Gendelman,et al.  Cell-mediated drug delivery , 2011, Expert opinion on drug delivery.

[306]  J. Kreuter Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB) , 2013, Journal of microencapsulation.

[307]  Kyoungju Choi,et al.  Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity , 2017, Nanotoxicology.

[308]  D. Begley,et al.  Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[309]  Yu-Wen Wu,et al.  Circulatory-cell-mediated nanotherapeutic approaches in disease targeting. , 2017, Drug discovery today.

[310]  Beom-Jin Lee,et al.  Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles , 2017, Journal of Pharmaceutical Investigation.

[311]  L. Yang,et al.  A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood–brain barrier, and the transporting mechanism to glioma cells , 2017, International journal of nanomedicine.

[312]  P. White,et al.  Characterizing Nanoparticles in Biological Matrices: Tipping Points in Agglomeration State and Cellular Delivery In Vitro. , 2017, ACS nano.

[313]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.